Beyond 12 months: maintenance phase The SURMOUNT-4 trial clearly showed that ongoing tirzepatide treatment maintains weight loss, while discontinuation leads to regain
17 Glucagon-like peptide 1 (GLP-1) is an incretin hormone secreted from the L cells in the gut, which has numerous physiological actions, including stimulation of insulin secretion in a glucose-dependent manner, inhibition of glucagon release, suppressing appetite, slowing gastric emptying and food intake
Blood pressure changes were minimal in most participants at lower doses
Its part of the process, and its important to give yourself grace
World Alzheimer Report 2018: The state of the art of dementia research: New frontiers
It creates a bridge between medicated weight management and unmedicated weight management